MHRA consultation on statutory fees (2026)

Proposals for ongoing cost-recovery and to fund higher value services.

This consultation closes at
11:59pm on 25 September 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) is seeking views on proposals to update statutory fees charged from 1 April 2027. The proposals are intended to ensure the MHRA continues to recover the cost of delivering its regulatory services while driving further improvements in service reliability, predictability and timeliness. They include increases to most fees in line with inflation, targeted changes for selected services, enhanced service standards and support for eligible small and medium-sized enterprises, and improvements to scientific advice and medical device post-market surveillance services.

We are seeking views on the following proposals:

Please provide your responses using our secure online form.

We will close our consultation on changes to statutory fees on 25 September 2026.

MHRA consultation on statutory fees (2026) webinar

View our recent webinar, including delegate Q&A, that provided an overview of the consultation proposals, explained the rationale behind them, and outlined how stakeholders can submit their views.

This file may not be suitable for users of assistive technology.